Xtant Historical Income Statement
| XTNT Stock | USD 0.40 0.01 2.44% |
Historical analysis of Xtant Medical income statement accounts such as Interest Expense of 5.3 M, Total Revenue of 53.7 M, Gross Profit of 34 M or Other Operating Expenses of 60.4 M can show how well Xtant Medical Holdings performed in making a profits. Evaluating Xtant Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Xtant Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Xtant Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xtant Medical Holdings is a good buy for the upcoming year.
Xtant |
About Xtant Income Statement Analysis
Xtant Medical Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Xtant Medical shareholders. The income statement also shows Xtant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Xtant Medical Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Xtant Medical Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Xtant Medical Holdings minus its cost of goods sold. It is profit before Xtant Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Xtant Medical Holdings. It is also known as Xtant Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Xtant Medical Holdings income statement and represents the costs associated with goods and services Xtant Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Xtant Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Xtant Medical's Reconciled Depreciation is comparatively stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 32.5M | 32.1M | 55.5M | 34.0M | Total Revenue | 55.3M | 58.0M | 91.3M | 53.7M |
Xtant Medical income statement Correlations
Click cells to compare fundamentals
Xtant Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xtant Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 5.8M | 6.0M | 995K | 1.7M | 2.9M | 5.3M | |
| Total Revenue | 64.7M | 53.3M | 55.3M | 58.0M | 91.3M | 53.7M | |
| Gross Profit | 42.5M | 34.4M | 32.5M | 32.1M | 55.5M | 34.0M | |
| Other Operating Expenses | 66.9M | 54.1M | 59.1M | 64.7M | 101.5M | 60.4M | |
| Operating Income | (2.4M) | (751K) | (3.9M) | (6.8M) | (10.2M) | (10.7M) | |
| Ebit | (2.4M) | (767K) | (3.9M) | (6.7M) | 1.9M | 2.0M | |
| Ebitda | 789K | 1.3M | (2.5M) | (5.4M) | 5.1M | 5.3M | |
| Cost Of Revenue | 22.2M | 18.9M | 22.8M | 25.8M | 35.8M | 19.8M | |
| Total Operating Expenses | 44.8M | 35.1M | 36.3M | 38.9M | 65.6M | 40.7M | |
| Income Before Tax | (8.1M) | (6.7M) | (4.8M) | (8.4M) | (1.0M) | (1.1M) | |
| Net Income | (8.2M) | (7.0M) | (5.8M) | (8.5M) | 660K | 693K | |
| Depreciation And Amortization | 3.1M | 2.1M | 1.3M | 1.3M | 3.2M | 3.1M | |
| Selling General Administrative | 17.9M | 13.5M | 14.4M | 15.5M | 25.9M | 14.3M | |
| Total Other Income Expense Net | (5.8M) | (6.0M) | (995K) | (1.7M) | 9.1M | 9.6M | |
| Income Tax Expense | 98K | 296K | 995K | 69K | (1.7M) | (1.6M) | |
| Selling And Marketing Expenses | 25.8M | 21.0M | 21.0M | 22.5M | 38.4M | 27.5M | |
| Research Development | 932K | 657K | 870K | 915K | 1.3M | 1.4M | |
| Net Income From Continuing Ops | (8.2M) | (7.0M) | (4.8M) | (8.5M) | 2.8M | 2.9M | |
| Net Income Applicable To Common Shares | (8.2M) | (7.0M) | (4.8M) | (8.5M) | (9.8M) | (10.2M) | |
| Tax Provision | 98K | 296K | 322K | 69K | (2.3M) | (2.4M) | |
| Interest Income | 10.0M | 5.8M | 0.0 | 31K | 164K | 155.8K | |
| Net Interest Income | (5.8M) | (6.0M) | (995K) | (1.7M) | (2.5M) | (2.6M) | |
| Non Operating Income Net Other | 127.8K | 124K | (98K) | 31K | 27.9K | 26.5K | |
| Reconciled Depreciation | 3.1M | 2.1M | 1.3M | 1.3M | 2.5M | 2.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.